Literature DB >> 10201997

Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice.

C Mora1, F S Wong, C H Chang, R A Flavell.   

Abstract

The NOD (nonobese diabetic) mouse is a good animal model for human IDDM. MHC class II-restricted CD4 T cells are necessary for the onset of diabetes in NOD mice. Here, we demonstrate that NOD mice lacking the CIITA (class II transactivator) molecule, and hence deficient in MHC class II expression and peripheral CD4 T cells, show significant pancreatic infiltration but do not develop diabetes. CD4 T cell deficiency, then, does not prevent initial pancreatic infiltration, but does stop progression to insulitis. Adoptive transfer studies show that the paucity of CD4 T cells in NOD-CIITA knockout mice is responsible for the absence of diabetes, since the CD8 T cell and B cell compartments are functional. An autoaggressive CD8+ T cell clone can, however, transfer diabetes in CIITA knockout recipient mice without CD4 T cell help, albeit with some delay compared with that in CIITA-sufficient recipients. This highlights the fact that a high number of in vitro activated autoaggressive CD8 T cells can over-ride the requirement for CD4 T cell help for the onset of diabetes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10201997

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Class II transactivator: mastering the art of major histocompatibility complex expression.

Authors:  J A Harton; J P Ting
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  In CD4+ T-cell-induced diabetes, macrophages are the final effector cells that mediate islet beta-cell killing: studies from an acute model.

Authors:  Boris Calderon; Anish Suri; Emil R Unanue
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

3.  Cathepsin L is essential for onset of autoimmune diabetes in NOD mice.

Authors:  René Maehr; Justine D Mintern; Ann E Herman; Ana-Maria Lennon-Duménil; Diane Mathis; Christophe Benoist; Hidde L Ploegh
Journal:  J Clin Invest       Date:  2005-09-22       Impact factor: 14.808

Review 4.  Type 1 diabetes pathogenesis and the role of inhibitory receptors in islet tolerance.

Authors:  Tijana Martinov; Brian T Fife
Journal:  Ann N Y Acad Sci       Date:  2019-04-26       Impact factor: 5.691

Review 5.  RNA interference for improving the outcome of islet transplantation.

Authors:  Feng Li; Ram I Mahato
Journal:  Adv Drug Deliv Rev       Date:  2010-12-13       Impact factor: 15.470

6.  Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment.

Authors:  Tom L Van Belle; Therese Juntti; Jeanette Liao; Matthias G von Herrath
Journal:  J Autoimmun       Date:  2009-12-09       Impact factor: 7.094

7.  CD154 is a negative regulator of autoaggressive CD8+ T cells in type 1 diabetes.

Authors:  Catrin M McGregor; Stephen P Schoenberger; E Allison Green
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-10       Impact factor: 11.205

Review 8.  What can the HLA transgenic mouse tell us about autoimmune diabetes?

Authors:  F S Wong; L Wen
Journal:  Diabetologia       Date:  2004-09-02       Impact factor: 10.122

9.  CD4+ T cells are sufficient to elicit allograft rejection and major histocompatibility complex class I molecule is required to induce recurrent autoimmune diabetes after pancreas transplantation in mice.

Authors:  Zhidan Xiang; Lian-Li Ma; Santhakumar Manicassamy; Balaji B Ganesh; Phillip Williams; Ravi Chari; Anita Chong; Deng-Ping Yin
Journal:  Transplantation       Date:  2008-04-27       Impact factor: 4.939

10.  IFN-γ receptor deficiency prevents diabetes induction by diabetogenic CD4+, but not CD8+, T cells.

Authors:  Zuoan Yi; Li Li; Alaina Garland; Qiuming He; Haidong Wang; Jonathan D Katz; Roland Tisch; Bo Wang
Journal:  Eur J Immunol       Date:  2012-08       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.